129 related articles for article (PubMed ID: 31368060)
1. DHA Abolishes the Detrimental Effect of Docetaxel on Downregulation of the MICA via Decreasing the Expression Level of MicroRNA-20a in Gastric Cancer.
Shekari N; Javadian M; Ghaffari S; Baradaran B; Darabi M; Kazemi T
J Gastrointest Cancer; 2020 Jun; 51(2):545-551. PubMed ID: 31368060
[TBL] [Abstract][Full Text] [Related]
2. Synergistic Beneficial Effect of Docosahexaenoic Acid (DHA) and Docetaxel on the Expression Level of Matrix Metalloproteinase-2 (MMP-2) and MicroRNA-106b in Gastric Cancer.
Shekari N; Javadian M; Ghasemi M; Baradaran B; Darabi M; Kazemi T
J Gastrointest Cancer; 2020 Mar; 51(1):70-75. PubMed ID: 30680612
[TBL] [Abstract][Full Text] [Related]
3. Let-7a Could Serve as A Biomarker for Chemo-Responsiveness to Docetaxel in Gastric Cancer.
Shekari N; Asghari F; Haghnavaz N; Shanehbandi D; Khaze V; Baradaran B; Kazemi T
Anticancer Agents Med Chem; 2019; 19(3):304-309. PubMed ID: 30543177
[TBL] [Abstract][Full Text] [Related]
4. Altered Expression of CD44, SIRT1, CXCR4, miR-21, miR-34a, and miR-451 Genes in MKN-45 Cell Line After Docetaxel Treatment.
Motamedi M; Razmkhah F; Rezakhani L; Ghasemi S
J Gastrointest Cancer; 2020 Jun; 51(2):520-526. PubMed ID: 31273630
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of the human major histocompatibility complex class I chain-related gene A (MICA) and its receptor is mediated by microRNA-146b-5p and is a potential mechanism of immunoediting in papillary thyroid carcinoma.
Al-Abdallah A; Jahanbani I; Mehdawi H; Ali RH; Al-Brahim N; Mojiminiyi O; Junaid TA
Exp Mol Pathol; 2020 Apr; 113():104379. PubMed ID: 31935378
[TBL] [Abstract][Full Text] [Related]
6. Synergistic anticancer properties of docosahexaenoic acid and 5-fluorouracil through interference with energy metabolism and cell cycle arrest in human gastric cancer cell line AGS cells.
Gao K; Liang Q; Zhao ZH; Li YF; Wang SF
World J Gastroenterol; 2016 Mar; 22(10):2971-80. PubMed ID: 26973393
[TBL] [Abstract][Full Text] [Related]
7. Involvement of miR-20a in promoting gastric cancer progression by targeting early growth response 2 (EGR2).
Li X; Zhang Z; Yu M; Li L; Du G; Xiao W; Yang H
Int J Mol Sci; 2013 Aug; 14(8):16226-39. PubMed ID: 23924943
[TBL] [Abstract][Full Text] [Related]
8. Docosahexaenoic acid (DHA) inhibits pro-angiogenic effects of breast cancer cells via down-regulating cellular and exosomal expression of angiogenic genes and microRNAs.
Aslan C; Maralbashi S; Kahroba H; Asadi M; Soltani-Zangbar MS; Javadian M; Shanehbandi D; Baradaran B; Darabi M; Kazemi T
Life Sci; 2020 Oct; 258():118094. PubMed ID: 32673663
[TBL] [Abstract][Full Text] [Related]
9. Long chain n-3 polyunsaturated fatty acids increase the efficacy of docetaxel in mammary cancer cells by downregulating Akt and PKCε/δ-induced ERK pathways.
Chauvin L; Goupille C; Blanc C; Pinault M; Domingo I; Guimaraes C; Bougnoux P; Chevalier S; Mahéo K
Biochim Biophys Acta; 2016 Apr; 1861(4):380-90. PubMed ID: 26821209
[TBL] [Abstract][Full Text] [Related]
10. miR-20a regulates sensitivity of colorectal cancer cells to NK cells by targeting MICA.
Tang S; Fu H; Xu Q; Zhou Y
Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 30988067
[TBL] [Abstract][Full Text] [Related]
11. Exosome-mediated microRNA signaling from breast cancer cells is altered by the anti-angiogenesis agent docosahexaenoic acid (DHA).
Hannafon BN; Carpenter KJ; Berry WL; Janknecht R; Dooley WC; Ding WQ
Mol Cancer; 2015 Jul; 14():133. PubMed ID: 26178901
[TBL] [Abstract][Full Text] [Related]
12. Expression of both poly r(C) binding protein 1 (PCBP1) and miRNA-3978 is suppressed in peritoneal gastric cancer metastasis.
Ji FJ; Wu YY; An Z; Liu XS; Jiang JN; Chen FF; Fang XD
Sci Rep; 2017 Nov; 7(1):15488. PubMed ID: 29138420
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of leucine-rich repeats and immunoglobulin-like domains 1 by microRNA-20a modulates gastric cancer multidrug resistance.
Zhou L; Li X; Zhou F; Jin Z; Chen D; Wang P; Zhang S; Zhuge Y; Shang Y; Zou X
Cancer Sci; 2018 Apr; 109(4):1044-1054. PubMed ID: 29450946
[TBL] [Abstract][Full Text] [Related]
14. miR-20a enhances cisplatin resistance of human gastric cancer cell line by targeting NFKBIB.
Du Y; Zhu M; Zhou X; Huang Z; Zhu J; Xu J; Cheng G; Shu Y; Liu P; Zhu W; Wang T
Tumour Biol; 2016 Jan; 37(1):1261-9. PubMed ID: 26286834
[TBL] [Abstract][Full Text] [Related]
15. Rosmarinic acid reduces the resistance of gastric carcinoma cells to 5-fluorouracil by downregulating FOXO4-targeting miR-6785-5p.
Yu C; Chen DQ; Liu HX; Li WB; Lu JW; Feng JF
Biomed Pharmacother; 2019 Jan; 109():2327-2334. PubMed ID: 30551491
[TBL] [Abstract][Full Text] [Related]
16. Docosahexaenoic acid (DHA) and linoleic acid (LA) modulate the expression of breast cancer involved miRNAs in MDA-MB-231 cell line.
Elieh Ali Komi D; Shekari N; Soofian-Kordkandi P; Javadian M; Shanehbandi D; Baradaran B; Kazemi T
Clin Nutr ESPEN; 2021 Dec; 46():477-483. PubMed ID: 34857238
[TBL] [Abstract][Full Text] [Related]
17. Docosahexaenoic acid reverses the promoting effects of breast tumor cell-derived exosomes on endothelial cell migration and angiogenesis.
Ghaffari-Makhmalbaf P; Sayyad M; Pakravan K; Razmara E; Bitaraf A; Bakhshinejad B; Goudarzi P; Yousefi H; Pournaghshband M; Nemati F; Fahimi H; Rohollah F; Hasanzad M; Hashemi M; Mousavi SH; Babashah S
Life Sci; 2021 Jan; 264():118719. PubMed ID: 33159957
[TBL] [Abstract][Full Text] [Related]
18. Docosahexaenoic acid may inhibit immune evasion of colorectal cancer cells through targeting immune checkpoint and immunomodulator genes and their controlling microRNAs.
Fadaee M; Abbasi H; Maralbashi S; Baradaran B; Shanehbandi D; Dinevari MF; Kazemi T
Biofactors; 2022 Sep; 48(5):1137-1144. PubMed ID: 35533068
[TBL] [Abstract][Full Text] [Related]
19. Omega-3 Polyunsaturated Fatty Acids Enhance Cisplatin Efficacy in Gastric Cancer Cells by Inducing Apoptosis via ADORA1.
Sheng H; Chen X; Liu B; Li P; Cao W
Anticancer Agents Med Chem; 2016; 16(9):1085-92. PubMed ID: 27025656
[TBL] [Abstract][Full Text] [Related]
20. METase promotes cell autophagy via promoting SNHG5 and suppressing miR-20a in gastric cancer.
Xin L; Zhou LQ; Liu L; Yuan YW; Zhang HT; Zeng F
Int J Biol Macromol; 2019 Feb; 122():1046-1052. PubMed ID: 30227213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
